Hemoconcentration as a prognostic factor after hospital discharge in acute heart failure in the RICA registry
| Autor: | J. Grau Amorós, F. Formiga, O. Aramburu Bodas, A. Armengou Arxe, A. Conde Martel, M.A. Quesada Simón, R. Oropesa Juanes, J.A. Satué Bartolomé, M.F. Dávila Ramos, M. Montero Pérez-Barquero, L. Anarte, O. Aramburu, J.C. Arévalo-Lorido, A. Armengou, A. Brase, S. Carrascosa, M. Carrera, J. Casado, J.M. Cerqueiro, A. Conde, M.F. Dávila, J. Díez-Manglano, F. Epelde, J. Franco, J. Gallego, D. García-Escrivá, A. González-Franco, J. Grau, M.E. Guisado, A. Herrero, P. Llacer, G. López-Castellanos, L. Manzano, A. Martínez-Zapico, M. Montero-Pérez-Barquero, A. Muela, R. Oropesa, C. Pérez-Bocanegra, J.I. Pérez-Calvo, J. Pérez-Silvestre, M.A. Quesada, R. Quirós, E.E. Rodríguez-Ávila, F. Ruiz-Laiglesia, R. Ruiz-Ortega, P. Salamanca, M. Sánchez-Marteles, J.A. Satué, A. Serrado, I. Suárez, J.C. Trullàs |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Prognostic factor
medicine.medical_specialty Multivariate analysis business.industry General Medicine Hemoconcentration Lower risk medicine.disease 03 medical and health sciences 0302 clinical medicine Quartile Statistical significance Internal medicine Heart failure Medicine 030212 general & internal medicine business Prospective cohort study |
| Zdroj: | Revista Clínica Española (English Edition). 219:1-9 |
| ISSN: | 2254-8874 |
| DOI: | 10.1016/j.rceng.2018.07.004 |
| Popis: | Objective Several studies have reported that a higher degree of hemoconcentration in patients admitted for the treatment of acute heart failure (HF) constitutes a favorable prognostic factor in the year following the index episode. The objective of this study was to evaluate whether the highest degree of hemoconcentration at 3 months after admission for HF is also a prognostic factor for mortality and/or readmission in the 12 months after admission. Patients and method The hemoconcentration group was the upper quartile of the sample distributed according to hemoglobin increase at month 3 after discharge with respect to hemoglobin at the time of admission for HF in a multicenter prospective cohort of 1659 subjects with HF. Results The mean follow-up until the first event was 294 days, and a total of 487 deaths and 1125 readmissions were recorded. The hemoconcentration group had a lower risk of mortality or readmission for any cause (RR = 0.75, 95% CI: 0.51–1.09 and RR = 0.86, 95% CI: 0.70–1.05), although statistical significance was lost after multivariate analysis, while it was retained for other factors with recognized negative impact on the prognosis of patients with HF, such as age and functional class. Conclusions The degree of hemoconcentration at 3 months after admission for HF is not prognostic of readmission or death in the subsequent year. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect